Sleep Problems Prior to Radio-chemotherapy in Patients With Locally Advanced Cancer of the Esophagus or the Esophagogastric Junction

被引:1
|
作者
Rades, Dirk [1 ,7 ]
Kopelke, Svenja [1 ,2 ]
Schild, Steven E. [3 ]
Tvilsted, Soeren [4 ]
Kjaer, Troels W. [5 ]
Bartscht, Tobias [2 ,6 ]
机构
[1] Univ Lubeck, Dept Radiat Oncol, Lubeck, Germany
[2] Univ Lubeck, Dept Hematol & Oncol, Lubeck, Germany
[3] Mayo Clin, Dept Radiat Oncol, Scottsdale, AZ USA
[4] Zealand Univ Hosp, Res Dept, Koge, Denmark
[5] Zealand Univ Hosp, Neurol Dept, Roskilde, Denmark
[6] Helios Hosp, Dept Hematol Oncol & Stem Cell Transplantat, Schwerin, Germany
[7] Univ Lubeck, Dept Radiat Oncol, Ratzeburger Allee 160, D-23562 Lubeck, Germany
关键词
Esophageal cancer; adenocarcinoma of the esophagogastric junction; radio-chemotherapy; sleep problems; prevalence; risk factors; ESOPHAGECTOMY; DOCETAXEL; CISPLATIN;
D O I
10.21873/anticanres.15955
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background/Aim: Many patients with locally advanced cancer of the esophagus or esophagogastric junction receive definitive or neoadjuvant radiochemotherapy. Patient anticipation of this treatment can cause or aggravate distress and sleep disorders. This study aimed to identify the prevalence of sleep disorders and risk factors. Patients and Methods: Thirty-eight patients assigned to radio-chemotherapy were retrospectively evaluated for pre-treatment sleep disorders. Investigated characteristics included age; sex; performance score; comorbidity index; emotional, physical or practical problems; tumor site; histology and grading; tumor stage; planned treatment; and relation to 2019 Coronavirus pandemic. Results: Sleep problems were reported by 15 patients (39.5%). Significant associations were found for higher distress scores (p=0.016) and greater numbers of emotional problems (p<0.0001). A trend was observed for greater numbers of physical problems (p=0.176). Conclusion: The prevalence of sleep problems
引用
收藏
页码:4529 / 4533
页数:5
相关论文
共 50 条
  • [31] Preoperative Radio-chemotherapy in Locally Advanced Rectal Cancer - Prognostic Value of Time Interval to Surgery on Cancer Specific Survival
    Sole, C.
    Russo, M.
    Ovalle, V.
    Rivera, R.
    Sole, S.
    Frelinghuysen, M.
    Baeza, M.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S407 - S407
  • [32] Types of failures after concomitant radio-chemotherapy and ''boost in field'' with or without surgery for locally advanced cervix cancer
    Nagy, V
    Ghilezan, N
    Todor, N
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 945 - 945
  • [33] FDG PET for staging of advanced non-small cell lung cancer prior to neoadjuvant radio-chemotherapy
    S. Eschmann
    G. Friedel
    F. Paulsen
    W. Budach
    C. Harer-Mouline
    B. Dohmen
    R. Bares
    European Journal of Nuclear Medicine and Molecular Imaging, 2002, 29 : 804 - 808
  • [34] FDG PET for staging of advanced non-small cell lung cancer prior to neoadjuvant radio-chemotherapy
    Eschmann, SM
    Friedel, G
    Paulsen, F
    Budach, W
    Harer-Mouline, C
    Dohmen, BM
    Bares, R
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2002, 29 (06) : 804 - 808
  • [35] Nuclear factor-kB (NF-kB) predicts outcome in locally advanced rectal cancer patients receiving radio-chemotherapy
    Berardi, R.
    Mandolesi, A.
    Bearzi, I.
    Scartozzi, M.
    Mantello, G.
    Onofri, A.
    Pierantoni, C.
    Marmorale, C.
    Fianchini, A.
    Cascinu, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [36] THE RANDOMIZED STUDY COMPARING THE EFFICACY AND SAFETY OF RADIO-CHEMOTHERAPY PLUS ADJUVANT CHEMOTHERAPY (CCRT) VS. NEO-ADJUVANT CHEMOTHERAPY PLUS RADIO-CHEMOTHERAPY (NAC-RT) FOR LOCALLY ADVANCED NASOPHARYNGEAL CANCER
    Chakrabandhu, S.
    Chitapanarux, I.
    Jiratrachu, R.
    Pruegsanusak, K.
    Pinitpatcharalerd, A.
    Sukhaboon, J.
    Tovanabutra, C.
    Srisuthep, A.
    Prasongsook, N.
    Lorvidhaya, V.
    ANNALS OF ONCOLOGY, 2012, 23 : 339 - 340
  • [37] Concomitant radio-chemotherapy and brachytherapy for advanced cervical cancer: outcomes and toxicity
    Pollara, L.
    Cuccia, F.
    Figlia, V.
    Palmeri, A.
    Gueci, M.
    Luca, N.
    Aiello, D.
    Evangelista, G.
    Sciume, F.
    RADIOTHERAPY AND ONCOLOGY, 2016, 119 : S935 - S936
  • [38] Cancer stem cell phenotype relates to radio-chemotherapy outcome in locally advanced squamous cell head-neck cancer
    Koukourakis, M. I.
    Giatromanolaki, A.
    Tsakmaki, V.
    Danielidis, V.
    Sivridis, E.
    BRITISH JOURNAL OF CANCER, 2012, 106 (05) : 846 - 853
  • [39] ASPECTS OF COMBINED RADIO-CHEMOTHERAPY IN ADVANCED HEAD AND NECK-CANCER
    ZAMBOGLOU, N
    SCHMIDT, C
    PAPE, H
    FURST, G
    SCHMITT, G
    TUMORDIAGNOSTIK & THERAPIE, 1988, 9 : 35 - 40
  • [40] Perioperative (radio)chemotherapy for locally advanced rectal cancer
    Hofheinz, R. -D.
    ONKOLOGE, 2015, 21 (02): : 117 - 128